Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 281

1.

Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study.

Giardino ND, Curtis JL, Andrei AC, Fan VS, Benditt JO, Lyubkin M, Naunheim K, Criner G, Make B, Wise RA, Murray SK, Fishman AP, Sciurba FC, Liberzon I, Martinez FJ; NETT Research Group.

Respir Res. 2010 Mar 9;11:29. doi: 10.1186/1465-9921-11-29.

2.

Prevalence and clinical correlates of bronchoreversibility in severe emphysema.

Han MK, Wise R, Mumford J, Sciurba F, Criner GJ, Curtis JL, Murray S, Sternberg A, Weinman G, Kazerooni E, Fishman AP, Make B, Hoffman EA, Mosenifar Z, Martinez FJ; NETT Research Group.

Eur Respir J. 2010 May;35(5):1048-56. doi: 10.1183/09031936.00052509. Epub 2009 Nov 19.

3.

Integrating health status and survival data: the palliative effect of lung volume reduction surgery.

Benzo R, Farrell MH, Chang CC, Martinez FJ, Kaplan R, Reilly J, Criner G, Wise R, Make B, Luketich J, Fishman AP, Sciurba FC; NETT Research Group.

Am J Respir Crit Care Med. 2009 Aug 1;180(3):239-46. doi: 10.1164/rccm.200809-1383OC. Epub 2009 May 29.

4.

Continuous oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of patients: retrospective analysis of the National Emphysema Treatment Trial.

Drummond MB, Blackford AL, Benditt JO, Make BJ, Sciurba FC, McCormack MC, Martinez FJ, Fessler HE, Fishman AP, Wise RA; NETT Investigators.

Chest. 2008 Sep;134(3):497-506. doi: 10.1378/chest.08-0117. Epub 2008 Jul 18.

PMID:
18641094
5.

Longitudinal change in the BODE index predicts mortality in severe emphysema.

Martinez FJ, Han MK, Andrei AC, Wise R, Murray S, Curtis JL, Sternberg A, Criner G, Gay SE, Reilly J, Make B, Ries AL, Sciurba F, Weinmann G, Mosenifar Z, DeCamp M, Fishman AP, Celli BR; National Emphysema Treatment Trial Research Group.

Am J Respir Crit Care Med. 2008 Sep 1;178(5):491-9. doi: 10.1164/rccm.200709-1383OC. Epub 2008 Jun 5.

6.

Changes in arterial oxygenation and self-reported oxygen use after lung volume reduction surgery.

Snyder ML, Goss CH, Neradilek B, Polissar NL, Mosenifar Z, Wise RA, Fishman AP, Benditt JO; National Emphysema Treatment Trial Research Group.

Am J Respir Crit Care Med. 2008 Aug 15;178(4):339-45. doi: 10.1164/rccm.200712-1826OC. Epub 2008 Jun 5.

8.

Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease.

Fan VS, Ramsey SD, Giardino ND, Make BJ, Emery CF, Diaz PT, Benditt JO, Mosenifar Z, McKenna R Jr, Curtis JL, Fishman AP, Martinez FJ; National Emphysema Treatment Trial (NETT) Research Group.

Arch Intern Med. 2007 Nov 26;167(21):2345-53.

PMID:
18039994
9.

Estimating pulmonary artery pressures by echocardiography in patients with emphysema.

Fisher MR, Criner GJ, Fishman AP, Hassoun PM, Minai OA, Scharf SM, Fessler HE; NETT Research Group.

Eur Respir J. 2007 Nov;30(5):914-21. Epub 2007 Jul 25.

10.

Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema.

Criner GJ, Scharf SM, Falk JA, Gaughan JP, Sternberg AL, Patel NB, Fessler HE, Minai OA, Fishman AP; National Emphysema Treatment Trial Research Group.

Am J Respir Crit Care Med. 2007 Aug 1;176(3):253-60. Epub 2007 May 11.

11.

Sex differences in severe pulmonary emphysema.

Martinez FJ, Curtis JL, Sciurba F, Mumford J, Giardino ND, Weinmann G, Kazerooni E, Murray S, Criner GJ, Sin DD, Hogg J, Ries AL, Han M, Fishman AP, Make B, Hoffman EA, Mohsenifar Z, Wise R; National Emphysema Treatment Trial Research Group.

Am J Respir Crit Care Med. 2007 Aug 1;176(3):243-52. Epub 2007 Apr 12.

12.

Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group.

Naunheim KS, Wood DE, Mohsenifar Z, Sternberg AL, Criner GJ, DeCamp MM, Deschamps CC, Martinez FJ, Sciurba FC, Tonascia J, Fishman AP; National Emphysema Treatment Trial Research Group.

Ann Thorac Surg. 2006 Aug;82(2):431-43.

PMID:
16888872
13.

The effects of pulmonary rehabilitation in the national emphysema treatment trial.

Ries AL, Make BJ, Lee SM, Krasna MJ, Bartels M, Crouch R, Fishman AP; National Emphysema Treatment Trial Research Group.

Chest. 2005 Dec;128(6):3799-809.

PMID:
16354848
14.

One hundred years of chronic obstructive pulmonary disease.

Fishman AP.

Am J Respir Crit Care Med. 2005 May 1;171(9):941-8. No abstract available.

PMID:
15849329
15.

Acute hypoxia and pulmonary vasoconstriction in humans: uncovering the mechanism of the pressor response.

Fishman AP.

Am J Physiol Lung Cell Mol Physiol. 2004 Nov;287(5):L893-4. No abstract available.

16.

A century of pulmonary hemodynamics.

Fishman AP.

Am J Respir Crit Care Med. 2004 Jul 15;170(2):109-13. Review. No abstract available.

PMID:
15242851
17.

Primary pulmonary arterial hypertension: a look back.

Fishman AP.

J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):2S-4S. Review.

18.

Clinical classification of pulmonary hypertension.

Fishman AP.

Clin Chest Med. 2001 Sep;22(3):385-91, vii. Review.

PMID:
11590835
19.

On keeping an eye on the right ventricle in sleep apnea.

Fishman AP.

Am J Respir Crit Care Med. 2001 Sep 15;164(6):913-4. No abstract available.

PMID:
11587968
20.

Changing concepts of the pulmonary plexiform lesion.

Fishman AP.

Physiol Res. 2000;49(5):485-92. Review.

21.

Epoprostenol (prostacyclin) and pulmonary hypertension.

Fishman AP.

Ann Intern Med. 2000 Mar 21;132(6):500-2. No abstract available.

PMID:
10733452
22.

The Fick principle and the steady state.

Fishman AP.

Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):692-3. No abstract available.

PMID:
10712308
23.

The fick principle and the steady state

Fishman AP.

Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 2):S692-3. No abstract available.

PMID:
10712379
24.

Hippocrates and contemporary medicine.

Fishman AP.

Trans Stud Coll Physicians Phila. 1998 Dec;20:41-50. No abstract available.

PMID:
10207525
25.

Report of the president of the College of Physicians of Philadelphia, 1998.

Fishman AP.

Trans Stud Coll Physicians Phila. 1998 Dec;20:1-5. No abstract available.

PMID:
10207521
26.

Report of the president of the College of Physicians of Philadelphia, 1997

Fishman AP.

Trans Stud Coll Physicians Phila. 1997 Dec;19:1-5. No abstract available.

PMID:
10207512
27.

Vasodilator therapy for primary pulmonary hypertension in children.

Barst RJ, Maislin G, Fishman AP.

Circulation. 1999 Mar 9;99(9):1197-208.

PMID:
10069788
28.

Aminorex to fen/phen: an epidemic foretold.

Fishman AP.

Circulation. 1999 Jan 5-12;99(1):156-61. Review. No abstract available.

PMID:
9884392
29.

Etiology and pathogenesis of primary pulmonary hypertension: a perspective.

Fishman AP.

Chest. 1998 Sep;114(3 Suppl):242S-247S. Review.

PMID:
9741576
30.

Mechanisms of proliferative and obliterative vascular diseases. Insights from the pulmonary and systemic circulations. NHLBI Workshop summary.

Fishman AP, Fishman MC, Freeman BA, Gimbrone MA, Rabinovitch M, Robinson D, Gail DB.

Am J Respir Crit Care Med. 1998 Aug;158(2):670-4. No abstract available.

PMID:
9700149
31.

Pulmonary hypertension--beyond vasodilator therapy.

Fishman AP.

N Engl J Med. 1998 Jan 29;338(5):321-2. No abstract available.

PMID:
9445414
32.

Appetite-suppressant drugs and primary pulmonary hypertension.

Fishman AP.

N Engl J Med. 1997 Feb 13;336(7):511; author reply 512-3. No abstract available.

PMID:
9019650
33.

Chronic pulmonary hypertension in sheep: temporal progression of lesions.

Schnader J, Schloo BL, Anderson W, Stephenson LW, Fishman AP.

J Surg Res. 1996 May;62(2):243-50.

PMID:
8632646
34.
35.

Respiratory activity in the facial nucleus in an in vitro brainstem of tadpole, Rana catesbeiana.

Liao G-S, Kubin L, Galante RJ, Fishman AP, Pack AI.

J Physiol. 1996 Apr 15;492 ( Pt 2):529-44.

36.

Workshop on pulmonary rehabilitation research. A commentary.

Cole TM, Fishman AP.

Am J Phys Med Rehabil. 1994 Apr;73(2):132-3. No abstract available.

PMID:
8148104
37.

Pulmonary rehabilitation research.

Fishman AP.

Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):825-33. No abstract available.

PMID:
8118655
38.

Pulmonary hypertension and chronic cor pulmonale.

Fishman AP, Palevsky HI.

Heart Dis Stroke. 1993 Jul-Aug;2(4):335-41. Review. No abstract available.

PMID:
8156186
39.

Role of lung inflation in control of air breath duration in African lungfish (Protopterus annectens).

Pack AI, Galante RJ, Fishman AP.

Am J Physiol. 1992 May;262(5 Pt 2):R879-84.

PMID:
1590481
40.

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, et al.

Ann Intern Med. 1991 Sep 1;115(5):343-9.

PMID:
1863023
41.

The management of primary pulmonary hypertension.

Palevsky HI, Fishman AP.

JAMA. 1991 Feb 27;265(8):1014-20. Review.

PMID:
1992195
42.
43.

The report of the American Heart Association task force on strategies to increase federal research funding.

Rosen MR, Strauss HC, Atkinson HG, Fishman AP, Francis CK, Katz AM, Watanabe AM, Abboud FM, Weisfeldt ML, Friedman WF, et al.

Circulation. 1990 Oct;82(4):1549-59. No abstract available.

PMID:
2401090
44.

Pulmonary veno-occlusive disease and its response to vasodilator agents.

Palevsky HI, Pietra GG, Fishman AP.

Am Rev Respir Dis. 1990 Aug;142(2):426-9.

PMID:
2382906
45.

Control of interbreath interval in the African lungfish.

Pack AI, Galante RJ, Fishman AP.

Am J Physiol. 1990 Jul;259(1 Pt 2):R139-46.

PMID:
2375423
46.

Chronic cor pulmonale. Etiology and management.

Palevsky HI, Fishman AP.

JAMA. 1990 May 2;263(17):2347-53. Review.

PMID:
2182919
47.

Reduction of thyrotropin-releasing hormone concentrations in central nervous system of African lungfish during estivation.

Kreider MS, Winokur A, Pack AI, Fishman AP.

Gen Comp Endocrinol. 1990 Mar;77(3):435-41.

PMID:
2110919
48.

The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension.

Weir EK, Rubin LJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Elliott CG, Fishman AP, Goldring RM, Groves BM, et al.

Am Rev Respir Dis. 1989 Dec;140(6):1623-30.

PMID:
2690706
49.

Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents.

Palevsky HI, Schloo BL, Pietra GG, Weber KT, Janicki JS, Rubin E, Fishman AP.

Circulation. 1989 Nov;80(5):1207-21.

PMID:
2805259
50.

Chromatographic demonstration of reversible changes in endothelial permeability.

Haselton FR, Mueller SN, Howell RE, Levine EM, Fishman AP.

J Appl Physiol (1985). 1989 Nov;67(5):2032-48.

PMID:
2480948

Supplemental Content

Loading ...
Support Center